BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18026974)

  • 1. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
    Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
    Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character.
    Yasuda M; Miyazawa M; Fujita M; Kajiwara H; Iida T; Hirasawa T; Muramatsu T; Murakami M; Mikami M; Saitoh K; Shimizu M; Takekoshi S; Osamura RY
    Oncol Rep; 2008 Jan; 19(1):111-6. PubMed ID: 18097583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
    Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1.
    Miyazawa M; Yasuda M; Fujita M; Hirasawa T; Kajiwara H; Hirabayashi K; Ogane N; Shimizu M; Asanuma H; Murakami M; Takekoshi S; Mikami M; Osamura RY
    Arch Gynecol Obstet; 2009 Jun; 279(6):789-96. PubMed ID: 18936945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and significance of HIF-1alpha and GLUT-3 in glioma.
    Liu Y; Li YM; Tian RF; Liu WP; Fei Z; Long QF; Wang XA; Zhang X
    Brain Res; 2009 Dec; 1304():149-54. PubMed ID: 19782666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue microarray and in situ hybridization study on hypoxia inducible factor 1alpha mRNA expression in epithelial ovarian tumor].
    Luo J; Peng ZL; Wang H; Cheng YF; Yang KX; Xie L; Qian XL; Zou Y
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):168-70. PubMed ID: 12795846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].
    Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX
    Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
    BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
    Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
    Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of hypoxia inducible factor-1alpha and insulin-like growth factor-II in gastric carcinoma: correlation with angiogenesis and prognosis].
    Ru GQ; Zhao ZS; Tang QL; Xu WJ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):905-8. PubMed ID: 17953839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
    XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
    Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
    BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
    Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
    Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
    Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K
    Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of extracellular matrix proteins in ovarian serous tumors.
    Salani R; Neuberger I; Kurman RJ; Bristow RE; Chang HW; Wang TL; Shih IeM
    Int J Gynecol Pathol; 2007 Apr; 26(2):141-6. PubMed ID: 17413980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.